1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Rising Geriatric Population
4.2.2. Increasing Prevalence of Communicable & Noncommunicable Diseases
4.2.3 Technological Advancements in Molecular Diagnostics
4.2.4. Rising Healthcare Expenditure
4.3. Restraints
4.3.1. Unfavorable Regulatory Frameworks
4.3.2. High Costs of Molecular Diagnostic Tests
4.4. Opportunities
4.4.1. Growing Scope in Emerging Economies
4.4.2. Increasing Focus on Companion Diagnostics
4.4.3. Rising Popularity of Direct-to-Consumer (DTC) Genetic Testing
4.5. Challenges
4.5.1. Shortage of Skilled Professionals
4.6. Industry & Technology Trends
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Adjacent/Related Market Analysis
5. Latin America Molecular Diagnostics Market Assessment—by Offering
5.1. Overview
5.2. Kits & Reagents
5.3. Instruments
5.4. Software & Services
6. Latin America Molecular Diagnostics Market Assessment—by Test Type
6.1. Overview
6.2. Laboratory Tests
6.3. Point-of-Care (POC) Tests
7. Latin America Molecular Diagnostics Market Assessment—by Technology
7.1. Overview
7.2. Polymerase Chain Reaction (PCR)
7.3. In Situ Hybridization (ISH)
7.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5. Microarrays
7.6. Sequencing
7.7. Mass Spectrometry
7.8. Other Technologies
8. Latin America Molecular Diagnostics Market Assessment—by Application
8.1. Overview
8.2. Infectious Diseases
8.2.1. Respiratory Diseases
8.2.2. Hepatitis
8.2.3. HIV
8.2.4. Chlamydia Trachomatis/Neisseria Gonorrhoeae
8.2.5. Human Papillomavirus (HPV)
8.2.6. Healthcare-Associated Infections (HAIs)
8.2.7. Other Infectious Diseases
8.3. Oncology
8.3.1. Breast Cancer
8.3.2. Colorectal Cancer
8.3.3. Lung Cancer
8.3.4. Prostate Cancer
8.3.5. Lymphoma
8.3.6. Leukemia
8.3.7. Cervical Cancer
8.3.8. Other Cancer Types
8.5. Respiratory Diseases
8.6. Genetic Testing
8.7. Neurological Diseases
8.8. Cardiovascular Diseases
8.9. Other Applications
9. Latin America Molecular Diagnostics Market Assessment—by End User
9.1. Overview
9.2. Hospitals & Clinics
9.3. Diagnostic Laboratories
9.4. Academic & Research Institutes
9.5. Other End Users
10. Latin America Molecular Diagnostics Market Assessment—by Country
10.1. Brazil
10.2. Mexico
10.3. Colombia
10.4. Argentina
10.5. Chile
10.6. Peru
10.7. Uruguay
10.8. Rest of Latin America
11. Competition Analysis
11.1. Overview
11.2. Competitive Benchmarking
11.3. Competitive Dashboard
11.3.1. Market Leaders
11.3.2. Market Differentiators
11.3.3. Vanguards
11.3.4. Emerging Companies
11.4. Market Share Analysis/Market Ranking, By Key Players (2022)
12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
12.1. Bio-Manguinhos (Brazil)
12.2. F. Hoffmann-La Roche Ltd. (Switzerland)
12.3. Thermo Fisher Scientific Inc. (U.S.)
12.4. Hologic, Inc. (U.S.)
12.5. Illumina, Inc. (U.S.)
12.6. OmicronLab (Mexico)
12.7. QIAGEN N.V. (Netherlands)
12.8. Danaher Corporation (U.S.)
12.9. Abbott Laboratories (U.S.)
12.10. Agilent Technologies, Inc. (U.S.)
( Note: SWOT Analysis of the Top 5 Companies Will Be Provided )
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Latin America Molecular Diagnostics Market Size, by Offering, 2022–2031 (USD Million)
Table 2 Latin America Molecular Diagnostics Kits & Reagents Market Size, by Country/Region, 2022–2031 (USD Million)
Table 3 Latin Molecular Diagnostics Instruments Market Size, by Country/Region, 2022–2031 (USD Million)
Table 4 Latin America Molecular Diagnostics Software & Services Market Size, by Country/Region, 2022–2031 (USD Million)
Table 5 Latin America Molecular Diagnostics Market Size, by Test Type, 2022–2031 (USD Million)
Table 6 Latin America Molecular Diagnostics for Laboratory Tests, by Country/Region, 2022–2031 (USD Million)
Table 7 Latin America Molecular Diagnostics for PoC Tests, by Country/Region, 2022–2031 (USD Million)
Table 8 Latin America Molecular Diagnostics Market Size, by Technology, 2022–2031 (USD Million)
Table 9 Latin America Molecular Diagnostics for Polymerase Chain Reaction (PCR), by Country/Region, 2022–2031 (USD Million)
Table 10 Latin America Molecular Diagnostics for In Situ Hybridization (ISH), by Country/Region, 2022–2031 (USD Million)
Table 11 Latin America Molecular Diagnostics for Isothermal Nucleic Acid Amplification Technology (INAAT), by Country/Region, 2022–2031 (USD Million)
Table 12 Latin America Molecular Diagnostics for Microarrays, by Country/Region, 2022–2031 (USD Million)
Table 13 Latin America Molecular Diagnostics for Mass Spectrometry, by Country/Region, 2022–2031 (USD Million)
Table 14 Latin America Molecular Diagnostics for Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 15 Latin America Other Technologies Market Size, by Country/Region, 2022–2031 (USD Million)
Table 16 Latin America Molecular Diagnostics Market Size, by Application, 2022–2031 (USD Million)
Table 17 Latin America Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 18 Latin America Molecular Diagnostics Market Size for Infectious Diseases Market Size, by Country/Region, 2022–2031 (USD Million)
Table 19 Latin America Infectious Disease Molecular Diagnostics Market Size for Respiratory Diseases, by Country/Region, 2022–2031 (USD Million)
Table 20 Latin America Infectious Disease Molecular Diagnostics Market Size for Hepatitis Testing, by Country/Region, 2022–2031 (USD Million)
Table 21 Latin America Infectious Disease Molecular Diagnostics Market Size for HIV Testing, by Country/Region, 2022–2031 (USD Million)
Table 22 Latin America Infectious Disease Molecular Diagnostics Market Size for CT/NG Testing, by Country/Region, 2022–2031 (USD Million)
Table 23 Latin America Infectious Disease Molecular Diagnostics Market Size for Human papillomavirus (HPV) Testing, by Country/Region, 2022–2031 (USD Million)
Table 24 Latin America Infectious Disease Molecular Diagnostics Market Size for Healthcare-associated Infections (HAIs) Testing, by Country/Region, 2022–2031 (USD Million)
Table 25 Latin America Molecular Diagnostics Market Size for Other Infectious Diseases Testing, by Country/Region, 2022–2031 (USD Million)
Table 26 Latin America Oncology Molecular Diagnostics Market Size, by Type, 2022–2031 (USD Million)
Table 27 Latin America Oncology Molecular Diagnostics Market Size, by Country/Region, 2022–2031 (USD Million)
Table 28 Latin America Oncology Molecular Diagnostics Market Size for Breast Cancer Testing, by Country/Region, 2022–2031 (USD Million)
Table 29 Latin America Oncology Molecular Diagnostics Market Size for Colorectal Cancer Testing, by Country/Region, 2022–2031 (USD Million)
Table 30 Latin America Oncology Molecular Diagnostics Market Size for Lung Cancer Testing, by Country/Region, 2022–2031 (USD Million)
Table 31 Latin America Oncology Molecular Diagnostics Market Size for Prostate Cancer Testing, by Country/Region, 2022–2031 (USD Million)
Table 32 Latin America Oncology Molecular Diagnostics Market Size for Lymphoma Testing, by Country/Region, 2022–2031 (USD Million)
Table 33 Latin America Oncology Molecular Diagnostics Market Size for Leukemia Testing, by Country/Region, 2022–2031 (USD Million)
Table 34 Latin America Oncology Molecular Diagnostics Market Size for Cervical Cancer Testing, by Country/Region, 2022–2031 (USD Million)
Table 35 Latin America Oncology Molecular Diagnostics Market Size for Other Cancer Types Testing, by Country/Region, 2022–2031 (USD Million)
Table 36 Latin America Genetic Testing Molecular Diagnostics Market Size, by Country/Region, 2022–2031 (USD Million)
Table 37 Latin America Neurological Diseases Molecular Diagnostics Market Size, by Country/Region, 2022–2031 (USD Million)
Table 38 Latin America Cardiovascular Diseases Molecular Diagnostics Market Size, by Country/Region, 2022–2031 (USD Million)
Table 39 Latin America Other Applications Molecular Diagnostics Market Size, by Country/Region, 2022–2031 (USD Million)
Table 40 Latin America Molecular Diagnostics Market Size, by End User, 2022–2031 (USD Million)
Table 41 Latin America Molecular Diagnostics Market Size for Hospitals & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 42 Latin America Molecular Diagnostics Market Size for Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 43 Latin America Molecular Diagnostics Market Size for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 44 Latin America Molecular Diagnostics Market Size for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 45 Latin America Molecular Diagnostics Market Size, by Country/Region, 2022–2031 (USD Million)
Table 46 Latin America: Molecular Diagnostics Market Size, by Offering, 2022–2031 (USD Million)
Table 47 Latin America: Molecular Diagnostics Market Size, by Test Type, 2022–2031 (USD Million)
Table 48 Latin America: Molecular Diagnostics Market Size, by Technology, 2022–2031 (USD Million)
Table 49 Latin America: Molecular Diagnostics Market Size, by Application, 2022–2031 (USD Million)
Table 50 Latin America: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 51 Latin America: Molecular Diagnostics Market Size for Oncology, by Type, 2022–2031 (USD Million)
Table 52 Latin America: Molecular Diagnostics Market Size, by End User, 2022–2031 (USD Million)
Table 53 Brazil: Molecular Diagnostics Market Size, by Offering, 2022–2031 (USD Million)
Table 54 Brazil: Molecular Diagnostics Market Size, by Test Type, 2022–2031 (USD Million)
Table 55 Brazil: Molecular Diagnostics Market Size, by Technology, 2022–2031 (USD Million)
Table 56 Brazil: Molecular Diagnostics Market Size, by Application, 2022–2031 (USD Million)
Table 57 Brazil: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 58 Brazil: Molecular Diagnostics Market Size for Oncology, by Type, 2022–2031 (USD Million)
Table 59 Brazil: Molecular Diagnostics Market Size, by End User, 2022–2031 (USD Million)
Table 60 Mexico: Molecular Diagnostics Market Size, by Offering, 2022–2031 (USD Million)
Table 61 Mexico: Molecular Diagnostics Market Size, by Test Type, 2022–2031 (USD Million)
Table 62 Mexico: Molecular Diagnostics Market Size, by Technology, 2022–2031 (USD Million)
Table 63 Mexico: Molecular Diagnostics Market Size, by Application, 2022–2031 (USD Million)
Table 64 Mexico: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 65 Mexico: Molecular Diagnostics Market Size for Oncology, by Type, 2022–2031 (USD Million)
Table 66 Mexico: Molecular Diagnostics Market Size, by End User, 2022–2031 (USD Million)
Table 67 Colombia: Molecular Diagnostics Market Size, by Offering, 2022–2031 (USD Million)
Table 68 Colombia: Molecular Diagnostics Market Size, by Test Type, 2022–2031 (USD Million)
Table 69 Colombia: Molecular Diagnostics Market Size, by Technology, 2022–2031 (USD Million)
Table 70 Colombia: Molecular Diagnostics Market Size, by Application, 2022–2031 (USD Million)
Table 71 Colombia: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 72 Colombia: Molecular Diagnostics Market Size for Oncology, by Type, 2022–2031 (USD Million)
Table 73 Colombia: Molecular Diagnostics Market Size, by End User, 2022–2031 (USD Million)
Table 74 Argentina: Molecular Diagnostics Market Size, by Offering, 2022–2031 (USD Million)
Table 75 Argentina: Molecular Diagnostics Market Size, by Test Type, 2022–2031 (USD Million)
Table 76 Argentina: Molecular Diagnostics Market Size, by Technology, 2022–2031 (USD Million)
Table 77 Argentina: Molecular Diagnostics Market Size, by Application, 2022–2031 (USD Million)
Table 78 Argentina: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 79 Argentina: Molecular Diagnostics Market Size for Oncology, by Type, 2022–2031 (USD Million)
Table 80 Argentina: Molecular Diagnostics Market Size, by End User, 2022–2031 (USD Million)
Table 81 Chile: Molecular Diagnostics Market Size, by Offering, 2022–2031 (USD Million)
Table 82 Chile: Molecular Diagnostics Market Size, by Test Type, 2022–2031 (USD Million)
Table 83 Chile: Molecular Diagnostics Market Size, by Technology, 2022–2031 (USD Million)
Table 84 Chile: Molecular Diagnostics Market Size, by Application, 2022–2031 (USD Million)
Table 85 Chile: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 86 Chile: Molecular Diagnostics Market Size for Oncology, by Type, 2022–2031 (USD Million)
Table 87 Chile: Molecular Diagnostics Market Size, by End User, 2022–2031 (USD Million)
Table 88 Peru: Molecular Diagnostics Market Size, by Offering, 2022–2031 (USD Million)
Table 89 Peru: Molecular Diagnostics Market Size, by Test Type, 2022–2031 (USD Million)
Table 90 Peru: Molecular Diagnostics Market Size, by Technology, 2022–2031 (USD Million)
Table 91 Peru: Molecular Diagnostics Market Size, by Application, 2022–2031 (USD Million)
Table 92 Peru: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 93 Peru: Molecular Diagnostics Market Size for Oncology, by Type, 2022–2031 (USD Million)
Table 94 Peru: Molecular Diagnostics Market Size, by End User, 2022–2031 (USD Million)
Table 95 Uruguay: Molecular Diagnostics Market Size, by Offering, 2022–2031 (USD Million)
Table 96 Uruguay: Molecular Diagnostics Market Size, by Test Type, 2022–2031 (USD Million)
Table 97 Uruguay: Molecular Diagnostics Market Size, by Technology, 2022–2031 (USD Million)
Table 98 Uruguay: Molecular Diagnostics Market Size, by Application, 2022–2031 (USD Million)
Table 99 Uruguay: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 100 Uruguay: Molecular Diagnostics Market Size for Oncology, by Type, 2022–2031 (USD Million)
Table 101 Uruguay: Molecular Diagnostics Market Size, by End User, 2022–2031 (USD Million)
Table 102 Rest of Latin America: Molecular Diagnostics Market Size, by Offering, 2022–2031 (USD Million)
Table 103 Rest of Latin America: Molecular Diagnostics Market Size, by Test Type, 2022–2031 (USD Million)
Table 104 Rest of Latin America: Molecular Diagnostics Market Size, by Technology, 2022–2031 (USD Million)
Table 105 Rest of Latin America: Molecular Diagnostics Market Size, by Application, 2022–2031 (USD Million)
Table 106 Rest of Latin America: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 107 Rest of Latin America: Molecular Diagnostics Market Size for Oncology, by Type, 2022–2031 (USD Million)
Table 108 Rest of Latin America: Molecular Diagnostics Market Size, by End User, 2022–2031 (USD Million)
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for the Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Latin America Molecular Diagnostics Market, by Offering, 2022–2031 (USD Million)
Figure 8 Latin America Molecular Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Figure 9 Latin America Molecular Diagnostics Market, by Technology, 2022–2031 (USD Million)
Figure 10 Latin America Molecular Diagnostics Market, by Application, 2022–2031 (USD Million)
Figure 11 Latin America Molecular Diagnostics Market, by End User, 2022–2031 (USD Million)
Figure 12 Latin America Molecular Diagnostics Market, by Country/Region
Figure 13 Market Dynamics: Latin America Molecular Diagnostics Market
Figure 14 Latin America Molecular Diagnostics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 15 Latin America Molecular Diagnostics Market, by Test Type, 2024 Vs. 2031 (USD Million)
Figure 16 Latin America Molecular Diagnostics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 17 Latin America Molecular Diagnostics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 18 Latin America Molecular Diagnostics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 19 Latin America Molecular Diagnostics Market, by Country/Region, 2024 Vs. 2031 (USD Million)
Figure 20 Latin America Molecular Diagnostics Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players (2020–2023)
Figure 22 Latin America Molecular Diagnostics Market: Competitive Benchmarking, by Type
Figure 23 Latin America Molecular Diagnostics Market: Competitive Dashboard
Figure 24 Latin America Molecular Diagnostics Market: Market Share Analysis (2023)
Figure 25 F. Hoffmann-La Roche Ltd.: Financial Overview (2022)
Figure 26 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 27 Hologic, Inc.: Financial Overview (2022)
Figure 28 Illumina, Inc.: Financial Overview (2022)
Figure 29 QIAGEN N.V.: Financial Overview (2022)
Figure 30 Danaher Corporation: Financial Overview (2022)
Figure 31 Abbott Laboratories: Financial Overview (2022)
Figure 32 Agilent Technologies, Inc.: Financial Overview (2023)